The market for saliva testing has dried up. Shield T3, the University of Illinois' for-profit subsidiary spun out of researchers' PCR saliva testing technology, is winding down operations, U of I ...

Co-leaders of COVID-19 testing initiative Shield Illinois are taking what they learned from standing up a massive saliva-based virus testing operation and sharing it through a business consultancy.

URBANA, Ill. (WAND) - The University of Illinois System’s Shield T3 LLC will wind down operations by the end of December, system President Tim Killeen announced Monday. Shield T3 is a for-profit ...

The U.S. Food and Drug Administration on Monday approved a new blood test that can spot colon cancer. In late May, an FDA advisory panel had voted 7-2 that the benefits outweigh the risks when using ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced new real-world data published in Current Medical Research and Opinion finding that the Shield blood-based ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Centers for Medicare & Medicaid Services (CMS) has approved Advanced ...